UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 222

Sortiert nach

Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells

Cell death and differentiation, 2015-06, Vol.22 (6), p.898-911

2015

Volltextzugriff (PDF)

Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status

British journal of cancer, 2011-11, Vol.105 (10), p.1533-1541

2011

Volltextzugriff (PDF)

Molecular testing of gliomas

Annals of oncology, 2018-09, Vol.29, p.vi30-vi30

2018

Volltextzugriff (PDF)

422 Our experience with HER2 screening of the bioptic breast cancer samples using the method fluorescence in situ hybridization in the year 2014 - application of the updated ASCO/CAP guideline recommendations

European journal of cancer (1990), 2015-09, Vol.51, p.S85-S86

2015

Volltextzugriff (PDF)

Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction

Folia biologica, 2013-01, Vol.59 (5), p.181-187

2013

Volltextzugriff (PDF)

NOD2/CARD15 mutations and the risk of reoperation in patients with Crohns disease

Rozhledy v chirurgii, 2015-06, Vol.94 (6), p.242

2015

Volltextzugriff (PDF)

Serum levels of matrix metalloproteinases 2 and 9 and TGFBR2 gene screening in patients with ascending aortic dilatation

Folia biologica, 2013-01, Vol.59 (4), p.154-161

2013

Volltextzugriff (PDF)

Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy

Journal of B.U. ON., 2009-09, Vol.14 Suppl 1, p.S169

2009

Volltextzugriff (PDF)

89PDistribution of somatic mutations in PIK3CA gene in breast colorectal and colorectal Czech cancer patients - selected colorectal cancer patients with angiogenesis inhibitors treatment

Annals of oncology, 2019-11, Vol.30 (Supplement_7)

2019

Volltextzugriff (PDF)

Distribution of somatic mutations in PIK3CA gene in breast colorectal and colorectal Czech cancer patients - selected colorectal cancer patients with angiogenesis inhibitors treatment

Annals of oncology, 2019-11, Vol.30, p.vii26

2019

Volltextzugriff (PDF)

94PMolecular testing of gliomas

Annals of oncology, 2018-09, Vol.29 (suppl_6)

2018

Volltextzugriff (PDF)

297 Therapy of murine HPV 16-associated TC-1 tumours: suppression of T regulatory and myeloid derived suppressor cells

European journal of cancer supplements, 2010, Vol.8 (5), p.77-77

2010

Volltextzugriff (PDF)

Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16

British journal of cancer, 2001-02, Vol.84 (3), p.374-380

2001

Volltextzugriff (PDF)

Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines

Oncotarget, 2016-08, Vol.7 (34), p.54952-54964

2016

Volltextzugriff (PDF)

Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin

International journal of oncology, 2002-03, Vol.20 (3), p.643

2002

Volltextzugriff (PDF)

Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines

International journal of oncology, 2010-03, Vol.36 (3), p.545-551

2010

Volltextzugriff (PDF)

Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A

Oncology reports, 2001-11, Vol.8 (6), p.1371

2001

Volltextzugriff (PDF)

Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I‐deficient and ‐proficient HPV16‐associated tumours

International journal of cancer, 2006-04, Vol.118 (7), p.1836-1842

2006

Volltextzugriff (PDF)

Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours

International journal of oncology, 2003-07, Vol.23 (1), p.243

2003

Volltextzugriff (PDF)

CpG oligodeoxynucleotides are effective in therapy of minimal residual tumour disease after chemotherapy or surgery in a murine model of MHC class I-deficient, HPV16-associated tumours

International journal of oncology, 2007-05, Vol.30 (5), p.1247-1251

2007

Volltextzugriff (PDF)

Minimal residual disease as the target for immunotherapy and gene therapy of cancer (review)

Oncology reports, 2005-11, Vol.14 (5), p.1377

2005

Volltextzugriff (PDF)

Intratumoral IL-2 Gene Transfer Improves the Therapeutic Efficacy of IL-12 but Not IL-18

Folia biologica, 2000-01, Vol.46 (5), p.191-193

2000

Volltextzugriff (PDF)

Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF

International journal of oncology, 2004-01, Vol.24 (1), p.161

2004

Volltextzugriff (PDF)

Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours

International journal of oncology, 2007-04, Vol.30 (4), p.1011-1017

2007

Volltextzugriff (PDF)

Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice

Immunology letters, 1988-12, Vol.19 (4), p.279-282

1988

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(163)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(112)
Animals
(74)
Mice
(61)
Oncology
(58)
Humans
(54)
Male
(51)
Biological And Medical Sciences
(41)
Female
(31)
Medical Sciences
(31)
Mice, Inbred C57bl
(31)
Biochemistry & Molecular Biology
(26)
Cell Biology
(26)
Biology
(24)
Life Sciences & Biomedicine - Other Topics
(24)
Neoplasm Transplantation
(20)
Ecology
(18)
Immunotherapy
(18)
Middle Aged
(18)
Adult
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells

Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status

Molecular testing of gliomas

422 Our experience with HER2 screening of the bioptic breast cancer samples using the method fluorescence in situ hybridization in the year 2014 - application of the updated ASCO/CAP guideline recommendations

Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction

NOD2/CARD15 mutations and the risk of reoperation in patients with Crohns disease

Serum levels of matrix metalloproteinases 2 and 9 and TGFBR2 gene screening in patients with ascending aortic dilatation

Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy

89PDistribution of somatic mutations in PIK3CA gene in breast colorectal and colorectal Czech cancer patients - selected colorectal cancer patients with angiogenesis inhibitors treatment

Distribution of somatic mutations in PIK3CA gene in breast colorectal and colorectal Czech cancer patients - selected colorectal cancer patients with angiogenesis inhibitors treatment

94PMolecular testing of gliomas

297 Therapy of murine HPV 16-associated TC-1 tumours: suppression of T regulatory and myeloid derived suppressor cells

Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16

Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines

Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin

Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines

Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A

Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I‐deficient and ‐proficient HPV16‐associated tumours

Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours

CpG oligodeoxynucleotides are effective in therapy of minimal residual tumour disease after chemotherapy or surgery in a murine model of MHC class I-deficient, HPV16-associated tumours

Minimal residual disease as the target for immunotherapy and gene therapy of cancer (review)

Intratumoral IL-2 Gene Transfer Improves the Therapeutic Efficacy of IL-12 but Not IL-18

Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF

Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours

Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice

Suchergebnisse filtern